NanoLogix Inc. Announces Historical First in Energy Generation with Bioreactor-Produced Hydrogen at Welch's
HUBBARD, Ohio, Sept. 17 / / -- NanoLogix, Inc. , a nano-biotechnology company, announced it has achieved a historical event with the first onsite generation of electricity using hydrogen gas produced from its bioreactor prototype facility at Welch Foods Inc., a Cooperative in Pennsylvania.
A 5.5 kW generator converted to run on hydrogen was utilized for the demonstration. The generator ran flawlessly on hydrogen gas produced by NanoLogix's hydrogen bioreactor system and powered multiple strings of 100- watt light bulbs. "To the best of our knowledge, this is the first time in history that electricity has been generated anywhere onsite using hydrogen produced through the use of bacteria to digest waste", said Harry Diz, Department Chair and Professor of Environmental Engineering at Gannon University and NanoLogix Bioreactor Development chief.
Paul Zorzie, Welch's Engineering Manager, stated, "Welch's is happy to provide the site at which this groundbreaking research into generating alternative energy from waste is taking place. We look forward to the potential of building upon these developments to scale up and use this energy for our operation."
Bret Barnhizer, Chairman and CEO of NanoLogix, stated, "We are delighted at the results of the work by Professor Diz and associates and anticipate potential upscaling of the Welch's operation to commercial bioreactor status. The Welch's development, enabling conversion of sugar from their wastewater stream to produce hydrogen, has contributed immeasurably to ongoing research and development for processing other types of waste streams. Linked to that development and following our business plan for expansion, in the spring of 2008 we intend to begin bioreactor construction at the Erie Wastewater Treatment Plant for the extraction of hydrogen from their protein-rich activated sludge waste stream."
About NanoLogix, Inc.
NanoLogix is a leading innovator in the research, development, and commercialization of nano-biotechnologies, applications and processes. The Company has 31 granted Patents and 36 Patents Pending for bioreactor-based hydrogen production, revolutionary rapid medical testing technologies, potential treatments for sepsis and cancer, and bioremediation. Information on NanoLogix is available at http://www.nanologixinc.com/.
Source: NanoLogix Inc.
Web site: http://www.nanologixinc.com/
